B-lymphoblastic Lymphoma

• CLINICAL_TRIALS trial_result · 2026-04-24
  Clinical Trial Update: A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia [Phase 3]

  Phase 3 trial evaluating blinatumomab in combination with chemotherapy for newly diagnosed B lymphoblastic leukemia; the study is currently …

• CLINICAL_TRIALS trial_result · 2026-02-25
  Clinical Trial Update: Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia [Phase 1, Phase 2]

  Phase 1/2 trial evaluating the combination of venetoclax and vincristine in adults with relapsed or refractory B- or T-cell acute lymphoblas…

• CLINICAL_TRIALS research · 2026-02-23
  Clinical Trial Update: Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia [Phase 2]

  A Phase 2 clinical trial evaluating Besponsa (inotuzumab ozogamicin) for younger patients with CD22-positive B-acute lymphoblastic leukemia …

• CLINICAL_TRIALS research · 2026-02-12
  Clinical Trial Update: Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia [NA]

  A clinical trial is evaluating how different hemoglobin threshold-specific packed red blood cell transfusion strategies affect quality of li…

• CLINICAL_TRIALS trial_result · 2022-09-28
  Clinical Trial Update: Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma [Phase 2]

  Phase 2 clinical trial update for a pediatric therapy in relapsed or refractory precursor B-cell acute lymphoblastic leukemia and lymphoma; …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2020-06-23
  Clinical Trial Update: Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma [Phase 3]

  A Phase 3 clinical trial update reports results of a risk-adapted chemotherapy approach for younger patients with newly diagnosed standard-r…